Active Pharmaceutical Ingredients Market Industrial Progress 2018 to 2026

Active Pharmaceutical Ingredients Market
Industrial Progress 2018 to 2026
Active Pharmaceutical Ingredients Market – Global Industry Insights, Trends,
Outlook, and Opportunity Analysis, 2018-2026
Active Pharmaceutical Ingredients (API) are active constituents used in the manufacturing of
pharmaceutical formulations and have a pharmacological and therapeutic effects on the body. API
constitutes the main ingredient, which helps cure the disease or disorder. APIs provide health benefits
and are used in disease diagnosis, prevention, and treatment. APIs cannot be used in the raw form
because it is the crude form of drug, which will not meet the appropriate pharmacodynamics and
pharmacokinetics parameters. APIs are thus combined with the suitable excipients which are
pharmacologically and therapeutically inactive but enhance its stability and activities. Click To Read
More On Active Pharmaceutical Ingredients Market.
Any drug is composed of two components, the first one is the active pharmaceutical ingredient, which
is the central ingredient of the drug and the second is an excipient. Certain drugs such as combination
therapies, have numerous active ingredients, which treat different symptoms or act in different ways.
Manufacturers use different standards to determine the strength of an API.
Increasing prevalence of chronic diseases is expected to boost the active pharmaceutical
ingredients market over the forecast period
According to World Health Organization (WHO), mortality and global health estimates of 2015,
Ischaemic heart disease, stroke, chronic obstructive lung disease, and lower respiratory infections have
been the cause for maximum number of deaths during the past decade. Diabetes caused 1.6 million
(2.8%) deaths in 2015, from 1.0 million (1.8%) deaths in 2000. Deaths due to dementias doubled
between 2000 and 2015, making it the 7th leading cause of global deaths in 2015. The increasing
prevalence of chronic diseases is expected to increase the demand for drugs, in turn fueling the active
pharmaceutical ingredients market in the near future.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/738
According to World Health Organization (WHO), Non-Communicable Disease fact sheet 2017,
equivalent to 70% of all deaths globally. Each year, 15 million people die from a NCD between the age
range of 30 and 69 years, over 80% of these premature deaths occur in low- and average-income
countries. Cardiovascular diseases account for most NCD deaths, with 17.7 million deaths annually,
followed by cancers (8.8 million), respiratory diseases (3.9million), and diabetes (1.6 million)
contributing over 80% of all premature NCD deaths. The increase in non-communicable disease is also
expected to increase the demand for drug, lending growth for the active pharmaceutical ingredients
market in the future. With busier lifestyles, unhealthy diet patterns, including the consumption of junk
food and tobacco, and alcohol, are factors making the future generation more prone to contracting
diseases due to a weak immune system.
TAPI (Teva Active Pharmaceutical Ingredients) is the foremost producer of APIs in the globe, with 75
years of experience, Dr. Reddy’s is another leading producer with over 60 APIs, Cipla was the first
company to fully develop and produce active pharmaceutical ingredients. Aurobindo, Sandoz,
Ranbaxy, Sun Pharma are other leading players. In 2017, Government of India, in the draft
pharma policy, has proposed ‘peak customs duty’ for all active pharmaceutical ingredients (API) that
are made in India, this is expected to drive global API’s manufacturing companies to expand their
business in India.
Cumulative prevalence of non-communicable diseases in Africa is expected to fuel the active
pharmaceutical ingredients market over the forecast period
Regional market for active pharmaceutical ingredients by Coherent Market Insights, is segmented into
North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Africa is expected to
hold a dominant position in the active pharmaceutical ingredients market in the future due to the
increasing prevalence of non-communicable diseases in the region. According to WHO, 2015, NCD
deaths are projected to increase by 15% globally, between 2010 and 2020. The Asia Pacific region is
expected to be the fastest emerging region in the Active Pharmaceutical Ingredients Market owing to
the increasing consumption of tobacco, alcohol, unhealthy diet, and physical inactivity observed among
the populace, which are expected to cause chronic diseases.
Government plans bulk drugs parks,
import curbs to boost manufacturing in India
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

Active Pharmaceutical Ingredients (API) are active constituents used in the manufacturing of pharmaceutical formulations and have a pharmacological and therapeutic effects on the body. API constitutes the main ingredient, which helps cure the disease or disorder. APIs provide health benefits and are used in disease diagnosis, prevention, and treatment.

Download Report